Atopic Dermatitis Clinical Trials

A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 230 clinical trials
Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

Subacute and Chronic Atopic Dermatitis. The aim of this study is to evaluate the safety and efficacy of ADSTEM Inj. against Placebo in the treatment of atopic dermatitis in patients with moderate to

topical agents
atopy
  • 202 views
  • 22 Mar, 2022
  • 2 locations
Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

mild or moderate atopic dermatitis (AD) based on vIGA-AD. Cohort 2 and Cohort 3 will be performed in parallel and may commence after results are available from ARQ-151-212, a Phase 2 study evaluating

eczema
  • 42 views
  • 24 Feb, 2022
  • 8 locations
The Effectiveness of Antibacterial Therapeutic Clothing Based on Silver or Chitosan as Compared With Non-antibacterial Therapeutic Clothing in Patients With Moderate to Severe Atopic Dermatitis (ABC project)

Since 2000 therapeutic clothing or functional textiles based on silver or chitosan as antibacterial agents were introduced as therapeutics of atopic dermatitis (AD). These agents aim to reduce

antibiotics
atopy
antihistamines
staphylococcus aureus
  • 0 views
  • 01 Mar, 2022
  • 1 location
Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis

This is a phase II, double blind study with ZEP-3NA 0.1% or 1% vs. vehicle-control in subjects with mild to moderate Atopic Dermatitis. The IP (Investigational Product) will be administered

tubal ligation
hysterectomy
atopy
  • 8 views
  • 19 Apr, 2022
  • 6 locations
Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis

The purpose of this study is to evaluate the efficacy and safety of Jaktinib in participants with moderate to severe atopic dermatitis.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Apremilast 30 mg BID Combined With Dupilumab

Open label phase 2 investigational study of efficacy and safety of apremilast 30 mg BID in chronic atopic dermatitis when added to the FDA approved treatment dupilumab for atopic dermatitis that

dupilumab
treatment regimen
vasectomy
atopy
  • 0 views
  • 02 Jun, 2021
  • 1 location
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients

A Phase I/IIa Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GM-XANTHO in Healthy Volunteers and to Investigate its Efficacy and Safety Profile in Atopic Dermatitis Patients

topical corticosteroid
antihistamines
atopy
body mass index
hysterectomy
  • 49 views
  • 27 Apr, 2022
  • 1 location
A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis

A randomised, adaptive design, double-blind, placebo-controlled, first-in-human, two-part study to investigate the safety, tolerability, PK and preliminary efficacy of multiple topical doses of BEN2293 in patients with mild to moderate AD.

  • 0 views
  • 26 Apr, 2022
  • 1 location
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis (BREEZE-AD-PEDS)

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatitis.

topical agents
topical corticosteroid
eczema
baricitinib
ly3009104
  • 123 views
  • 29 Apr, 2022
  • 10 locations
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

The objective of this study is to evaluate the safety, pharmacokinetics and tolerability of multiple doses of upadacitinib in pediatric participants with severe atopic dermatitis and to evaluate

topical agents
topical corticosteroid
eczema
atopy
calcineurin inhibitor
  • 239 views
  • 05 May, 2022
  • 13 locations